Cecilia Arana Yi

889 total citations
21 papers, 210 citations indexed

About

Cecilia Arana Yi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Cecilia Arana Yi has authored 21 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Cecilia Arana Yi's work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Cecilia Arana Yi is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Cecilia Arana Yi collaborates with scholars based in United States, Australia and Canada. Cecilia Arana Yi's co-authors include Srđan Verstovšek, Constantine S. Tam, Jörge E. Cortes, Kerry Culm-Merdek, Eunice S. Wang, William Blum, Callum M. Sloss, Patrick A. Zweidler‐McKay, Harry P. Erba and Daniel J. DeAngelo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Cecilia Arana Yi

18 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Arana Yi United States 8 100 80 71 55 35 21 210
Ryan J. Stubbins Canada 9 102 1.0× 94 1.2× 81 1.1× 80 1.5× 85 2.4× 26 286
Diego Quinones Raffo United States 9 152 1.5× 83 1.0× 72 1.0× 44 0.8× 38 1.1× 17 304
Sung‐Soo Yoon South Korea 9 152 1.5× 120 1.5× 58 0.8× 91 1.7× 15 0.4× 54 272
Jimmie H. Harvey United States 6 115 1.1× 168 2.1× 144 2.0× 49 0.9× 51 1.5× 9 285
Kenneth Anderson United States 9 131 1.3× 119 1.5× 78 1.1× 74 1.3× 9 0.3× 13 273
T. Haferlach Germany 7 197 2.0× 142 1.8× 118 1.7× 44 0.8× 24 0.7× 10 283
Yingwan Luo China 8 113 1.1× 79 1.0× 56 0.8× 46 0.8× 8 0.2× 29 244
Federico De Marchi United States 9 99 1.0× 71 0.9× 41 0.6× 46 0.8× 14 0.4× 14 193
Jean‐Valère Malfuson France 8 143 1.4× 142 1.8× 42 0.6× 50 0.9× 8 0.2× 15 250
Nathalie Javidi‐Sharifi United States 7 158 1.6× 177 2.2× 71 1.0× 44 0.8× 28 0.8× 16 326

Countries citing papers authored by Cecilia Arana Yi

Since Specialization
Citations

This map shows the geographic impact of Cecilia Arana Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Arana Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Arana Yi more than expected).

Fields of papers citing papers by Cecilia Arana Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Arana Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Arana Yi. The network helps show where Cecilia Arana Yi may publish in the future.

Co-authorship network of co-authors of Cecilia Arana Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Arana Yi. A scholar is included among the top collaborators of Cecilia Arana Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Arana Yi. Cecilia Arana Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greipp, Patricia T., Dragan Jevremović, James M. Foran, et al.. (2025). Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms. Leukemia Research. 155. 107734–107734.
2.
He, Rong, Patricia T. Greipp, David S. Viswanatha, et al.. (2024). Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience. Blood Advances. 8(18). 4807–4811. 2 indexed citations
3.
Peterson, Joshua M., et al.. (2024). Recurrent Nodular Fasciitis of the Oral Mucosa: Case Report and Review of the Literature. International Journal of Surgical Pathology. 33(4). 992–1000.
4.
Baranwal, Anmol, Mark E. Gurney, Aref Al‐Kali, et al.. (2024). The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance. Blood Advances. 8(12). 3130–3139. 5 indexed citations
5.
He, Rong, David S. Viswanatha, Phuong L. Nguyen, et al.. (2022). Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience. Blood Advances. 7(8). 1351–1355. 9 indexed citations
6.
Andritsos, Leslie A., et al.. (2019). <p>Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes</p>. Journal of Blood Medicine. Volume 10. 381–390. 5 indexed citations
7.
Andritsos, Leslie A., et al.. (2019). Spontaneous resolution of untreated diffuse large B‐cell lymphoma of maxillary bone after incisional biopsy. SHILAP Revista de lepidopterología. 7(11). 2082–2086. 7 indexed citations
8.
Kovacsovics, Tibor, Moshe Levy, Rachel J. Cook, et al.. (2019). A randomized phase II trial of CX-01 with standard therapy in elderly patients with acute myeloid leukemia (AML).. Journal of Clinical Oncology. 37(15_suppl). 7001–7001. 11 indexed citations
9.
Cortes, Jörge E., Daniel J. DeAngelo, Harry P. Erba, et al.. (2018). Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Blood. 132(Supplement 1). 26–26. 26 indexed citations
10.
11.
Czuchlewski, David R., et al.. (2017). Hemophagocytosis lymphocytosis presenting as pulmonary‐renal syndrome: a case report and literature review. Clinical Case Reports. 5(9). 1486–1489.
12.
Cleyrat, Cédric, Devon Chabot‐Richards, David T. Lynch, et al.. (2017). Leukemic Transformation of Post-Essential Thrombocythemia Myelofibrosis: A Unique Case Presenting with Double MPL and CALR Mutations. Blood. 130. 4215–4215. 3 indexed citations
13.
Patnaik, Mrinal M., Vikas Gupta, Jason Gotlib, et al.. (2016). Results from Ongoing Phase 2 Trial of SL-401 in Patients with Advanced, High-Risk Myeloproliferative Neoplasms Including Chronic Myelomonocytic Leukemia. Blood. 128(22). 4245–4245. 9 indexed citations
14.
Yi, Cecilia Arana, Constantine S. Tam, & Srđan Verstovšek. (2015). Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis. Future Oncology. 11(5). 719–733. 55 indexed citations
15.
Bansal, Pranshu, et al.. (2015). Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML). Clinical Case Reports. 4(1). 43–45. 1 indexed citations
16.
Yi, Cecilia Arana, Ghayathri Jeyakumar, Jörge E. Cortes, et al.. (2013). Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers. Leukemia Research. 38(1). 91–94. 2 indexed citations
17.
Yi, Cecilia Arana, Peter A. McCue, Marc Rosen, et al.. (2013). Sarcoidosis Mimicking Metastatic Bone Disease in Head and Neck Cancer. Seminars in Oncology. 40(5). 529–534. 5 indexed citations
18.
Martinez‐Outschoorn, Ubaldo, Diana Whitaker‐Menezes, Matías E. Valsecchi, et al.. (2013). Reverse Warburg Effect in a Patient With Aggressive B-Cell Lymphoma: Is Lactic Acidosis a Paraneoplastic Syndrome?. Seminars in Oncology. 40(4). 403–418. 34 indexed citations
19.
Yi, Cecilia Arana, AnneMarie W. Block, Sheila N.J. Sait, et al.. (2008). Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: Possible role of cytarabine. Leukemia Research. 32(7). 1043–1048. 13 indexed citations
20.
Yi, Cecilia Arana, Alfonso Quintás‐Cardama, Francis J. Giles, et al.. (2006). Advances in the Therapy of Chronic Idiopathic Myelofibrosis. The Oncologist. 11(8). 929–943. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan J. Stubbins Breakdown of academic impact, for papers by Diego Quinones Raffo Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by Jimmie H. Harvey Breakdown of academic impact, for papers by Kenneth Anderson Breakdown of academic impact, for papers by T. Haferlach Breakdown of academic impact, for papers by Yingwan Luo Breakdown of academic impact, for papers by Federico De Marchi Breakdown of academic impact, for papers by Jean‐Valère Malfuson Breakdown of academic impact, for papers by Nathalie Javidi‐Sharifi
Rankless by CCL
2026